ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

HSCSW Heart Test Laboratories Inc

0,0484
0,00 (0,00%)
Pré-mercado
Última atualização: 05:00:01
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Heart Test Laboratories Inc HSCSW NASDAQ Equity Warrant
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 0,0484 05:00:01
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,0484
mais cotações »

Notícias Recentes

Data Hora Fonte Título
20/05/202410:00GLOBEHeartSciences Announces Further Internationalization of its..
24/04/202410:00GLOBEHeartSciences Announces Grant of Fundamental Patent by the..
02/04/202417:15GLOBEHeartSciences to Present at the LD Micro Invitational XIV..
26/03/202410:00GLOBEHeartSciences Announces Podium Presentation at World..
14/03/202417:15GLOBEHeartSciences Reports Third Quarter Fiscal 2024 Financial..
12/03/202410:00GLOBEHeartSciences’ Announces Peer-Reviewed Publication..
06/03/202411:00GLOBEHeartSciences Announces Canada Patent Grant Covering..
26/02/202411:00GLOBEHeartSciences Adds Key Advisor to its Scientific Advisory..
12/02/202411:00GLOBEHeartSciences Expands its Scientific Advisory Board
01/02/202411:00GLOBEHeartSciences Appoints New Scientific Advisory Board Member
18/01/202410:00GLOBEHeartSciences Announces Results and Adjournment of Annual..
03/01/202418:15GLOBEHeartSciences Reminds Stockholders to Vote at the Upcoming..
14/12/202318:15GLOBEHeartSciences Reports Second Quarter Fiscal 2024 Financial..
05/12/202310:00GLOBEHeartSciences Receives FDA Confirmation for 510(k) Clearance..
20/11/202310:00GLOBEHeartSciences Announces Closing of License Agreements with..
13/11/202310:45GLOBEHeartSciences’ MyoVista® wavECGTM Selected for Heart..
19/10/202310:00GLOBEHeartSciences Issues Investor Update Highlighting Recent Key..
26/09/202309:00GLOBEHeartSciences Receives Two New Patent Allowances, Expanding..
25/09/202309:00GLOBEHeartSciences to Participate in the Maxim Group Virtual Tech..
21/09/202309:00GLOBEHeartSciences Signs Definitive Agreements with the Icahn..
14/09/202317:15GLOBEHeartSciences Reports First Quarter Fiscal 2024 Financial..
12/09/202317:15GLOBEHeartSciences to Present at the Gilmartin Group Emerging..
11/09/202317:15GLOBEHeartSciences Named Electrocardiography Advancement..
07/09/202310:00GLOBEHeartSciences Signs Distribution Agreement with MedPhy..
31/08/202310:00GLOBEHeartSciences Signs Distribution Agreement with FJ Medical,..
24/08/202310:00GLOBEHeartSciences’ MyoVista® wavECGTM Selected to be used in..
17/08/202310:00GLOBEHeartSciences Announces Further Expansion of Artificial..
27/07/202310:00GLOBEMyoVista wavECG goes into clinical use at the Naya Imaging..
19/07/202310:00GLOBEHeartSciences Provides Business Update and Reports Fiscal..

Seu Histórico Recente

Delayed Upgrade Clock